It's not a joke. These stocks really have a good shot at generating ginormous returns.
Guardant Health (NASDAQ:GH) was upgraded by stock analysts at BidaskClub from a “hold” rating to a “buy” rating in a research note issued on Thursday, BidAskClub reports. A number of other bro
Guardant Health Inc (NASDAQ:GH) COO Amirali Talasaz sold 2,729 shares of the firm’s stock in a transaction dated Monday, April 20th. The shares were sold at an average price of $72.56, for a total v
Guardant Health Inc (NASDAQ:GH) COO Amirali Talasaz sold 7,771 shares of the company’s stock in a transaction on Friday, April 17th. The stock was sold at an average price of $72.70, for a total tra

Guardant Health: Buy This Liquid Biopsy Leader

05:49pm, Tuesday, 21'st Apr 2020
Guardant360 and GuardantOMNI continue to see robust demand. The company is targeting an even bigger opportunity in cancer diagnostics space with LUNAR-1 and LUN
Allred Capital Management LLC increased its position in shares of Guardant Health Inc (NASDAQ:GH) by 2,247.4% in the 1st quarter, HoldingsChannel reports. The firm owned 446 shares of the company’s
Shares of Guardant Health Inc (NASDAQ:GH) have earned a consensus rating of “Buy” from the nine ratings firms that are covering the company, Marketbeat.com reports. Two equities research analysts
While Guardant Health, Inc. (NASDAQ:GH) shareholders are probably generally happy, the stock hasn't had particularly...
Cubist Systematic Strategies LLC trimmed its position in shares of Guardant Health Inc (NASDAQ:GH) by 98.8% in the 4th quarter, according to the company in its most recent filing with the Securities a
Frontier Capital Management Co. LLC boosted its holdings in Guardant Health Inc (NASDAQ:GH) by 13.2% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned
Guardant Health Inc (NASDAQ:GH) CEO Helmy Eltoukhy sold 2,701 shares of the stock in a transaction that occurred on Tuesday, April 14th. The stock was sold at an average price of $70.06, for a total t
An animal health company and a cancer diagnostics leader have already provided market-beating returns, and they will likely continue to do so.
Guardant Health Inc (NASDAQ:GH) CEO Helmy Eltoukhy sold 200 shares of the company’s stock in a transaction on Thursday, April 16th. The shares were sold at an average price of $70.01, for a total va
Baldwin Brothers Inc. MA lowered its position in Guardant Health Inc (NASDAQ:GH) by 72.5% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchang
Arden Trust Co acquired a new stake in Guardant Health Inc (NASDAQ:GH) during the first quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 7,409 shares of the compan
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE